Chaulagain CP - Search Results

1

New insights and modern treatment of AL amyloidosis.

Chaulagain CP, Comenzo RL. Chaulagain CP, et al. Curr Hematol Malig Rep. 2013 Dec;8(4):291-8. doi: 10.1007/s11899-013-0175-0. Curr Hematol Malig Rep. 2013. PMID: 24026941 Review.

2

One siRNA pool targeting the λ constant region stops λ light-chain production and causes terminal endoplasmic reticulum stress.

Zhou P, Ma X, Iyer L, Chaulagain C, Comenzo RL. Zhou P, et al. Blood. 2014 May 29;123(22):3440-51. doi: 10.1182/blood-2013-10-535187. Epub 2014 Apr 10. Blood. 2014. PMID: 24723680 Free article.

3

Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis.

Kaul E, Shah G, Chaulagain C, Comenzo RL. Kaul E, et al. Bone Marrow Transplant. 2014 Sep;49(9):1233. doi: 10.1038/bmt.2014.117. Epub 2014 Jun 16. Bone Marrow Transplant. 2014. PMID: 24933207 No abstract available.

4

How we treat systemic light-chain amyloidosis.

Chaulagain CP, Comenzo RL. Chaulagain CP, et al. Clin Adv Hematol Oncol. 2015 May;13(5):315-24. Clin Adv Hematol Oncol. 2015. PMID: 26352777 Review.

5

siRNA targeting the κ light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases.

Ma X, Zhou P, Wong SW, Warner M, Chaulagain C, Comenzo RL. Ma X, et al. Gene Ther. 2016 Oct;23(10):727-733. doi: 10.1038/gt.2016.50. Epub 2016 Jun 20. Gene Ther. 2016. PMID: 27383253

6

Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth.

Ma X, Wong SW, Zhou P, Chaulagain CP, Doshi P, Klein AK, Sprague K, Kugelmass A, Toskic D, Warner M, Miller KB, Lee L, Varga C, Comenzo RL. Ma X, et al. Among authors: chaulagain cp. Exp Hematol Oncol. 2018 Oct 16;7:27. doi: 10.1186/s40164-018-0119-4. eCollection 2018. Exp Hematol Oncol. 2018. PMID: 30356940 Free PMC article.

7

Stigmata of amyloidosis; external manifestations of internal disease.

Chaulagain CP, Comenzo RL. Chaulagain CP, et al. Br J Haematol. 2019 Jul;186(1):10. doi: 10.1111/bjh.15885. Epub 2019 Mar 27. Br J Haematol. 2019. PMID: 30916377 Free article. No abstract available.

8

Daratumumab-based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant Recipients.

Chaulagain CP, Diacovo JM, Elson L, Comenzo RL, Samaras C, Anwer F, Khouri J, Landau H, Valent J. Chaulagain CP, et al. Clin Lymphoma Myeloma Leuk. 2020 Mar;20(3):e137-e143. doi: 10.1016/j.clml.2019.12.022. Epub 2020 Jan 8. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32029395 Free PMC article. No abstract available.

9

How We Manage Systemic Immunoglobulin Heavy Chain Amyloidosis (AH Amyloidosis) and Immunoglobulin Heavy-and-Light-Chain Amyloidosis (AH/AL Amyloidosis).

Chaulagain CP, Herlitz LC, Fu J, Bilani N, Lucitt C, Comenzo RL. Chaulagain CP, et al. Clin Lymphoma Myeloma Leuk. 2020 Nov;20(11):e826-e831. doi: 10.1016/j.clml.2020.06.017. Epub 2020 Jun 28. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32703752 Free article. No abstract available.

10

Options for Chemotherapy and Scoring Response and Relapse.

Varga C, Chaulagain C. Varga C, et al. Hematol Oncol Clin North Am. 2020 Dec;34(6):1115-1131. doi: 10.1016/j.hoc.2020.07.005. Epub 2020 Sep 28. Hematol Oncol Clin North Am. 2020. PMID: 33099428 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters